Streetbeat News

Products Services

BLTE

Belite Bio, Inc (NASDAQ:BLTE) has received approval from the Human Research Ethics Committee (HREC) to initiate the Phase 3 clinical trial of Tinlarebant for Geographic Atrophy in Australia. Tinlarebant is intended to slow disease progression in patients with Stargardt Disease and Geographic Atrophy in advanced Dry Age-related Macular Degeneration. The drug has been granted Fast Track Designation and Rare Pediatric Disease Designation in the U.S., and Orphan Drug Designation in both the U.S. and Europe.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 3:16 pm

WIMI

WiMi has developed an autonomous system that generates models based on 3D intelligent algorithms. This system is expected to enhance the company's capabilities in the 3D technology space.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 3:15 pm

AAPL

HPQ

SSNLF

Major tech companies Apple Inc, Samsung Electronics Co, and HP Inc have halted new imports of laptops and tablets to India due to a sudden imposition of licensing requirements. The ban disrupts the industry and may lead to delayed product launches or shortages. This move is part of India's efforts to reduce import dependence and foster a tech manufacturing industry. The companies are now seeking to quickly obtain licenses.

Portfolio Pulse from Anusuya Lahiri

August 04, 2023 | 3:14 pm

META

Mark Zuckerberg, CEO of Meta Platforms Inc, has sparked speculation and amusement by sharing a WhatsApp conversation with his wife, Priscilla Chan, about a new octagon-shaped fighting cage in their backyard. Zuckerberg's enthusiasm for MMA and fitness is well-known, but his wife expressed concern about the impact on their grass. The tech mogul's fitness journey includes martial arts and a 4,000-calorie daily diet.

Portfolio Pulse from Sudhanshu Singh

August 04, 2023 | 3:13 pm

NKLA

Nikola Corp (NASDAQ:NKLA) has won shareholder approval to increase the authorized number of shares of common stock, which will allow the company to raise cash by issuing new shares as needed. The company plans to use the funds raised for the production ramp of its new hydrogen fuel cell electric vehicle and expansion of its hydrogen refueling network. Nikola will report its Q2 results on August 4, with expected revenue of $15.43 million and an EPS loss of $(0.22).

Portfolio Pulse from Anusuya Lahiri

August 04, 2023 | 3:13 pm

LLY

Eli Lilly and Company (LLY) announced that its LIBRETTO-431 study of Retevmo met its primary endpoint. The study was designed to evaluate the efficacy and safety of Retevmo in patients with treatment-naive RET fusion-positive non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 3:12 pm

BABA

Alibaba Group Holding Limited (NYSE:BABA) has been in the news for its artificial intelligence (AI) offerings and organizational restructuring initiatives. The company's cloud unit showcased two large language models (LLMs) as part of its efforts to democratize AI technology. Alibaba's cloud unit is preparing for a spin-off from its parent in 2024. Meanwhile, Alibaba's logistic arm Cainiao Network launched a half-day express delivery service in eight major Chinese cities. Cainiao plans to pursue an initial public offering in the next 12 to 18 months.

Portfolio Pulse from Anusuya Lahiri

August 04, 2023 | 3:09 pm

AAPL

DBVT

SPY

TSLA

The US markets experienced lower volatility ahead of the jobs report, with the S&P 500 settling lower. DBV Technologies and other penny stocks are being bought by insiders. In crypto, Shiba Inu outperformed Dogecoin and Pepe Coin, while Bitcoin, Ethereum, and Dogecoin fell amid rising jobless claims. Apple has been working on ChatGPT-like AI tech for years and is preparing for the iPhone 15 Pro launch. Tesla is gearing up for the launch of the 'Highland' Model 3. Hedge funds lost over $6B betting against US cruise lines and hotels.

Portfolio Pulse from Akanksha Bakshi

August 04, 2023 | 3:08 pm

ACIU

AC Immune has received FDA Fast Track designation for its ACI-24.060 anti-amyloid-beta (Abeta) active immunotherapy for the treatment of Alzheimer's disease.

Portfolio Pulse from Charles Gross

August 04, 2023 | 3:05 pm

GNZUF

TM

Toyota Motor Corp (TM) has formed a joint venture with autonomous driving tech company, Pony.ai, and Guangzhou Automobile Group Co Ltd (GNZUF) to create a self-driving taxi business in China. The venture will be established this year with an investment of over 1 billion yuan (~$139 million). The companies plan to launch a Robotaxi vehicle based on Toyota's pure EV brand. In 2020, Toyota invested $400 million in Pony.ai to boost collaboration. Toyota's Q1 FY24 sales revenue was ¥10.5 trillion ($76.98 billion), higher than ¥8.5 trillion ($65.56 billion) a year ago.

Portfolio Pulse from Lekha Gupta

August 04, 2023 | 3:03 pm